Janux Therapeutics Inc's total assets for Q3 2024 were $695.02M, an increase of 0.52% from the previous quarter. JANX total liabilities were $38.91M for the fiscal quarter, a 15.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.